The valve bladder syndrome: 20 Years later

Journal of Urology

Volumn 166, Issue 4, 2001, Pages 1406-1414

  Glassberg, Kenneth I ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Bladder; Diabetes insipidus; Hydronephrosis; Nephrogenic

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GROWTH FACTOR;

BLADDER DISEASE; BLADDER FUNCTION; COMPLIANCE (PHYSICAL); FOLLOW UP; HISTOLOGY; HUMAN; HYDRONEPHROSIS; KIDNEY CONCENTRATING CAPACITY; NEPHROGENIC DIABETES INSIPIDUS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; SURGICAL APPROACH; URETER DILATATION; URETHRA VALVE; URINARY DIVERSION; URINE INCONTINENCE; URINE VOLUME; URODYNAMICS; VALVE BLADDER SYNDROME;

EID: 0034819764     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)65796-5     Document Type: Review

References (85)

1. Methods of assessing obstruction in dilated ureters
2. The ureter in posterior urethral valves
3. Observations of the dilated ureter following posterior urethral valve ablation
4. Observations on persistently dilated ureter after posterior urethral valve ablation
5. Persistent ureteral dilatation following valve resection
6. Posterior urethral valves management
7. The bladder in boys with posterior urethral valves: A urodynamic assessment
8. Valve bladder syndrome
9. Persistent ureteral dilatation following valve resection
10. Anomalies of the urethra
11. Editorial comment
12. Current issues regarding posterior urethral valves
13. The urodynamic consequences of posterior urethral valves
14. Long-term status of patients with posterior urethral valves
15. Management of posterior urethral valves on the basis of urodynamic findings
16. Pronóstico de los pacientes con válvulas de uretra posterior según tratamiento inicial y su comportamiento urodinámico
17. Does neonatal pyeloureterostomy worsen bladder function in children with posterior urethral valves?
18. Residual urine, an important factor in the interpretation of cystometrogram, an experimentation study
19. Transurethral resection
20. Effect of disuse and restoration of function on vesical capacity
21. Functional and pharmacological effects of ureteral diversion
22. The temporarily defunctionalized bladder in children
23. Congenitally obstructed bladders: Fate after prolonged defunctionalization
24. A study of the sequelae of posterior urethral valves
25. The effect of temporary cutaneous diversion on ultimate bladder function
26. Are 'valve bladders' congenital or iatrogenic?
27. Cutaneous vesicostomy effect on bladder's eventual function
28. Non-compliant bladder resulting from posterior urethral valves
29. Comparative urodynamic findings after valve ablation, vesicostomy or proximal diversion
30. Urodynamic findings in boys with posterior urethral valves after treatment with primary valve ablation or vesicostomy and delayed ablation
31. Growth in boys with posterior urethral valves. Primary valve resection versus upper tract diversion
32. Debate with Bernard Churchill: Primary valve ablation vs. temporary diversion
33. The long-term outcome of posterior urethral valves treated with primary valve ablation and observation
34. Normal growth with renal insufficiency owing to posterior urethral valves: Value of long-term diversion, a twenty-year follow-up
35. Urine specific gravity-neglected and resurrected
36. Factors influencing patients and graft survival in 300 cadaveric pediatric renal transplants
37. The outcome of renal transplantation in children with posterior urethral valves
38. Results of renal transplantation in boys treated for posterior urethral valves
39. Renal transplantation in children with posterior urethral valves
40. Renal transplantation in children with posterior urethral valves revisited: A ten-year follow up
41. Role of the bladder in delayed failure of kidney transplants in boys with posterior urethral valves
42. Influence of initial therapy on progression of renal failure and body growth in children with posterior urethral valves
43. The management of posterior urethral valves by initial vesicostomy and delayed valve ablation
44. Lower urinary tract changes after early valve ablation in neonates and infants: Is early diversion warranted?
45. Complications of posterior urethral valve surgery and their prevention
46. Long-term outcome of boys with posterior urethral valves
47. Long-term urinary continence and renal function in neonates with posterior urethral valves
48. Posterior urethral valves: A study of urinary control after operation
49. Posterior urethral valves: Results and sequelae
50. Bladder dysfunction in boys with posterior urethral valves before and after puberty
51. Bladder dysfunction in boys with posterior urethral valves
52. Early detection of bladder dysfunction following posterior urethral valves ablation
53. Proximal urinary diversion in the management of posterior urethral valves: Is it necessary?
54. When can persistent upper tract dilation be accepted as residual dilatation in posterior urethral valve patients?
55. The management of unilateral poorly functioning kidneys in patients with posterior urethral valves
56. Congenital valves in the posterior urethra
57. Normal empty-bladder management: Effective therapy for the severe valve bladder
58. Natural filling cystometry in small boys with posterior urethral valves: Unstable valve bladders become stable during sleep
59. Loss of elasticity in dysfunctional bladders: Urodynamic and histochemical correlation
60. Collagen and elastin in the obstructed fetal bladder
61. Is lamina propria matrix responsible for normal bladder compliance?
62. Normal and anomalous development of the urinary tract
63. Bovine bladder compliance increases with normal fetal development
64. Developmental expression of interstitial collagen genes in fetal bladders
65. The fetal bladder: From embryology to developmental physiology
66. A unique new model to study the effects of urinary diversion of the developing rabbit bladder
67. Urethral valves and the potential for healing in very young patients
68. Prenatally detected posterior urethral valves: Is gestational age at detection a predictor of outcome?
69. Smooth muscle development in the obstructed fetal bladder
70. Fetal bladder histology
71. The effect of obstruction on the developing bladder
72. Physiologic levels of hydrostatic pressure result in upregulation of heparin binding EGF-like growth factor (HB-EGF) in cultured neonatal bladder smooth muscle cells
73. The effects of sustained hydrostatic pressure on select bladder smooth muscle cell functions
74. Inhibition of pressure induced bladder smooth muscle cell hyperplasia using CRM197
75. Captopril (an inhibitor of angiotensin converting enzyme) inhibits obstructive changes in the neonatal rabbit bladder
76. Effect of captopril on the prevention and regression of myocardial cell hypertrophy and interstitial fibrosis in pressure overload cardiac hypertrophy
77. Heparin-binding EGF-like growth factor is ah autocrine growth factor for human urothelial cells and is synthesized by epithelial and smooth muscle cells in the human bladder
78. Heparin-binding EGF-like growth factor expression increases selectively in bladder smooth muscle in response to lower urinary tract obstruction
79. Cutaneous vesicostomy experience in infants and children
80. Posterior urethral valves and other male urethral anomalies
81. The dilated posterior urethra I: Male
82. Secondary bladder neck obstruction in patients with urethral valves: Treatment with phenoxybenzamine
83. Persistent ureteral dilatation following valve resection
84. Alpha blocker therapy in children